Ohcanbohtosat - Line Nederby

High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4+ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens Dahkki Katrine Fladeland Iversen, Line Nederby, Thomas Lund, Torben Plesner

Viečča ollesdeavstta

Sensitive ligand-based protein quantification using immuno-PCR: A critical review of single-probe and proximity ligation assays Dahkki Marcus Celik Hansen, Line Nederby, Mads Okkels-Birk Henriksen, Maria Hansen, Charlotte Guldborg Nyvold

Viečča ollesdeavstta

Natural killer cell activity in prostate cancer patients treated with curative radiotherapy with or without androgen deprivation therapy: an observational study Dahkki Stine V. Eriksen, Christine V. Madsen, Signe Timm, Ahmed H. Zedan, Louise Raunkilde, Torben F. Hansen, Line Nederby

Viečča ollesdeavstta

Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy Dahkki Sinne Søberg Brun, Torben Frøstrup Hansen, Sara Witting Christensen Wen, Christa Haugaard Nyhus, Lisbeth Bertelsen, Anders Jakobsen, Torben Schjødt Hansen, Line Nederby

Viečča ollesdeavstta

Description of an activity-based enzyme biosensor for lung cancer detection Dahkki Paul W. Dempsey, Cristina-Mihaela Sandu, Ricardo Gonzalezirias, Spencer Hantula, Obdulia Covarrubias-Zambrano, Stefan H. Bossmann, Alykhan S. Nagji, Nirmal K. Veeramachaneni, Nezih O. Ermerak, Derya Kocakaya, Tunc Lacin, Bedrittin Yildizeli, Patrick Lilley, Sara W. C. Wen, Line Nederby, Torben F. Hansen, Ole Hilberg

Viečča ollesdeavstta